Bank of Montreal’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1
Closed -$8 3713
2024
Q3
$8 Buy
+1
New +$7 ﹤0.01% 3814
2024
Q2
Sell
-44,816
Closed -$340K 4021
2024
Q1
$340K Buy
+44,816
New +$409K ﹤0.01% 2705
2023
Q4
Sell
-38,224
Closed -$419K 4117
2023
Q3
$419K Buy
+38,224
New +$456K ﹤0.01% 2567
2022
Q3
Sell
-19,533
Closed -$328 4205
2022
Q2
$328 Buy
+19,533
New +$333K ﹤0.01% 2953
2022
Q1
Sell
-10,808
Closed -$438K 4207
2021
Q4
$438K Sell
10,808
-188,031
-95% -$8.57M ﹤0.01% 2491
2021
Q3
$10.5M Sell
198,839
-88,035
-31% -$4.8M ﹤0.01% 1264
2021
Q2
$16.4M Buy
286,874
+280,309
+4,270% +$14.9M 0.01% 1011
2021
Q1
$321K Sell
6,565
-4,182
-39% -$203K ﹤0.01% 2896
2020
Q4
$482K Buy
10,747
+3,657
+52% +$135K ﹤0.01% 2725
2020
Q3
$251K Buy
7,090
+4,258
+150% +$145K ﹤0.01% 2636
2020
Q2
$92K Buy
+2,832
New +$78.3K ﹤0.01% 3129
2020
Q1
Sell
-55,479
Closed -$1.93M 4333
2019
Q4
$1.93M Buy
+55,479
New +$1.84M ﹤0.01% 1900

Other funds holding HCAT

Bank of Montreal's HCAT Position: Q4 2024 in Review

Bank of Montreal sold out of Health Catalyst (HCAT) in Q4 2024, closing a stake of 1 share — an estimated $8 sold.

Bank of Montreal first reported a position in HCAT in Q4 2019 and held it in 12 quarters. The position peaked at $16.4M in Q2 2021. 167 funds tracked by Wall St. Rank hold HCAT as of Q4 2024.

  • Bank of Montreal reported no remaining Health Catalyst position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 1 Health Catalyst share in Q4 2024, an estimated $8.
  • Bank of Montreal first reported a position in Health Catalyst in Q4 2019 and held it in 12 quarters.
  • Bank of Montreal's Health Catalyst position peaked at $16.4M in Q2 2021.
  • 167 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.